Advertisement

Pediatric Surgery International

, Volume 35, Issue 1, pp 159–165 | Cite as

Melanoma in children, adolescents and young adults: anatomo-clinical features and prognostic study on 426 cases

  • Giovanni Bagnoni
  • Cristian Fidanzi
  • Angelo Massimiliano D’Erme
  • Paolo Viacava
  • Matteo Leoni
  • Silvia Strambi
  • Chiara Calani
  • Alessia Bertocchini
  • Riccardo Morganti
  • Claudio Spinelli
Original Article
  • 86 Downloads

Abstract

Purpose

This study was conducted to determine the difference in anatomo-pathological and prognostic features of cutaneous melanoma in children, adolescents and young adults.

Methods

This is a retrospective review on 383 young patients ≤ 39 years of age with cutaneous melanoma, in a period from 2006 to 2016 in Area Vasta Nord Ovest, Tuscany, Italy. We subdivided patients in three groups (children ≤ 14 years, adolescents 15–21 years, young adults 22–39 years). We correlated all the anatomo-pathological parameters with age groups.

Results

We identified a total of 426 cases of cutaneous melanoma on an overall total of 383 patients. Mean age at diagnosis for all the patients ≤ 39 years of age was 31.2 years: in group A was 11.2 years, in group B 19.2 years and in group C 32.5 years. Incidence, in the subjects between 0 and 14 years, is 14 cases per million inhabitants, between 15 and 21 years of 145, and between 22 and 39 years of 394. Global incidence was 1.6 case per million for group A, 8.9 cases per million for group B, 105 cases per million for group C. No statistically significative correlation could be described for clinical parameters and age groups.

Conclusions

Incidence of melanoma in our casuistry results as the highest in the world. These data open new study for this kind of cancer.

Keywords

Adolescent Children Melanoma Young adult Surgery 

References

  1. 1.
    Campbell LB, Kathryn L, Kreicher BA et al (2015) Melanoma incidence in children and adolescent: decreasing trends in the United States. J Pediatr 166:1505–1513CrossRefGoogle Scholar
  2. 2.
    Davar D, Bahrami A, Pappo AS, Kirkwood JM (2017) Malignant melanoma in the adolescent and young adult (AYA) population. In: Bleyer A et al (eds) Cancer in adolescents and young adults, 2rd edn. Springer, Berlin, pp 231–267Google Scholar
  3. 3.
    Lowe GC, Saavedra A, Reed KB et al (2014) Increasing incidence of melanoma among middle-aged adults: an epidemiologic study in Olmsted County, Minnesota. Mayo Clin Proc 89:52–59CrossRefGoogle Scholar
  4. 4.
    Reed KB, Brewer JD, Lohse CM,et al (2012) Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota. Mayo Clin Proc 87:328–334CrossRefGoogle Scholar
  5. 5.
    Purdue MP, Freeman LE, Anderson WF, Tucker MA (2008) Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J Investig Dermatol 128(12):2905–2908CrossRefGoogle Scholar
  6. 6.
    Downard CD, Rapkin LB, Gow KW (2007) Melanoma in children and adolescents. Surg Oncol 16:215–220CrossRefGoogle Scholar
  7. 7.
    Tracy ET, Aldrink JH (2016) Pediatric melanoma. Semin Pediatr Surg 25(5):290–298CrossRefGoogle Scholar
  8. 8.
    Paradela S, Fonseca E, Pita-Fernandez S et al (2010) Prognostic factors in melanoma in children and adolescents: a clinicopathologic, single-center study of 137 patients. Cancer 15:4334–4344CrossRefGoogle Scholar
  9. 9.
    Livestro DP, Kaine EM, Michaelson JS et al (2007) Melanoma in the young: differences and similarities with adult melanoma—a casematched controlled analysis. Cancer 110:614–624CrossRefGoogle Scholar
  10. 10.
    Berg P, Lindelof B (1997) Differences in malignant melanoma between children and adolescent. A 35-year epidemiological study. Arch Dermatol 133:295–297CrossRefGoogle Scholar
  11. 11.
    Mu E, Lange JR, Strousse JJ (2012) Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma. Cancer 118:2700–2707CrossRefGoogle Scholar
  12. 12.
    Lange JR, Dunkel IF, Shaw HM, Sober AJ (2009) Melanoma in children and teenagers. In: Balch CM, Houghton AN, Sober AJ et al (eds) Cutaneous Melanoma, 5th edn. Quality Medical Publishing, St. Louis, pp 351–361Google Scholar
  13. 13.
    Aldrink JH, Selim MA, Diesen DL et al (2009) Pediatric melanoma: a single-institution experience of 150 patients. J Pediatr Surg 44:1514–1521CrossRefGoogle Scholar
  14. 14.
    Strouse JJ, Fears TR, Tucker MA et al (2005) Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol 23(21):4735–4741CrossRefGoogle Scholar
  15. 15.
    Rapporto AIOM-AIRT (2013) http://www.AIRTUM.it. Accessed 5 Aug 2018
  16. 16.
    Steliarova-Foucher E, Colombet M, Ries LAG, Hesseling P, Moreno F, Shin HY, Stiller CA (2017) International incidence of childhood cancer, volume III (electronic version). International Agency for Research on Cancer, Lyon. http://iicc.iarc.fr/results/. Accessed 3 Aug 2018Google Scholar
  17. 17.
    Cronin KA, Lake AJ, Scott S et al (2018) Annual report to the Nation on the Status of cancer, part I: National cancer statistics. Cancer 124(12):2785–2800CrossRefGoogle Scholar
  18. 18.
    Jen M, Murphy M, Grant-Kels JM (2009) Childhood melanoma. Clin Dermatol 27:529–536CrossRefGoogle Scholar
  19. 19.
    Greene MH, Clark WH Jr, Tucker MA, Kraemer KH, Elder DE, Fraser MC (1985) High risk of malignant melanoma in melanomaprone families with dysplastic nevi. Ann Intern Med 102:458–465CrossRefGoogle Scholar
  20. 20.
    Kraemer KH, Lee MM, Scotto J (1987) Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 123:241–250CrossRefGoogle Scholar
  21. 21.
    Fazaa B, Zghal M, Bailly C, Zeglaoui F, Goucha S et al (2001) Melanoma in xeroderma pigmentosum: 12 cases. Ann Dermatol Venereol 128:503–506Google Scholar
  22. 22.
    Greene MH, Young TI, Clark WH Jr (1981) Malignant melanoma internal-transplant recipients. Lancet 1:1196–1199CrossRefGoogle Scholar
  23. 23.
    Swerdlow AJ, English JS, Qiao Z (1995) The risk of melanoma inpatients with congenital nevi: a cohort study. J Am Acad Dermatol 32:595–599CrossRefGoogle Scholar
  24. 24.
    Bittencourt FV, Marghoob AA, Kopf AW, Koenig KL, Bart RS (2000) Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis. Pediatrics 106:736–741CrossRefGoogle Scholar
  25. 25.
    Sreeraman Kumar R, Messina JL, Reed D, Navid F, Sondak VK (2016) Pediatric melanoma and atypical melanocytic neoplasms. Cancer Treat Res 167:331–369CrossRefGoogle Scholar
  26. 26.
    Kanavy HE, Gerstenblith MR (2011) Ultraviolet radiation and melanoma. Semin Cutan Med Surg 30:222–228CrossRefGoogle Scholar
  27. 27.
    Jae-Wook L, Sojin P, Hae-Kyoung H, Myung CG, Eun-Yi M (2018) Di-(2-ethylhexyl) phthalate enhances melanoma tumor growth via differential effect on M1- and M2-polarized macrophages in mouse model. Environ Pollut 233:833–843CrossRefGoogle Scholar
  28. 28.
    Grote K, Hobler C, Andrade AJ et al (2009) Sex differences in effects on sexual development in rat offsprinf after pre-and postnatal exposure to triphenyltin chloride. Toxicology 260:53–59CrossRefGoogle Scholar
  29. 29.
    Liu C, Zhao L, Wei L, Li L (2015) DEHP reduces thyroid hormones via interacting with hormone synthesis-related proteins, deiodinases, transthyretin, receptors, and hepatic enzymes in rats. Environ Sci Pollut Res Int 22:12711–12719CrossRefGoogle Scholar
  30. 30.
    Darbre PD, Harvey PW (2008) Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J Appl Toxicol 28:561–578CrossRefGoogle Scholar
  31. 31.
    Schnatter AR, Chen M, DeVilbiss EA, Lewis RJ, Gallagher EM (2018) Systematic review and meta-analysis of selected cancers in petroleum refinery workers. J Occup Environ Med 60(7):e329–e342CrossRefGoogle Scholar
  32. 32.
    Rusthon L (1993) Further follow up of mortality in a United Kingdom oil distribution centre cohort. Br J Ind Med 50(6):561–569Google Scholar
  33. 33.
    Wong O, Raabe GK (2000) A critical review of cancer epidemiology in the petroleum industry, with a meta-analysis of a combined database of more than 350,000 workers. Regul Toxicol Pharmacol 32(1):78–98CrossRefGoogle Scholar
  34. 34.
    Sorahan T (2007) Mortality of UK oil refinery and petroleum distribution workers, 1951–2003. Occup Med (Lond) 57(3):177–185CrossRefGoogle Scholar
  35. 35.
    Linabery AM, Ross JA (2008) Trends in childhood cancer incidence in the US (1992–2004). Cancer 112(2):416–432CrossRefGoogle Scholar
  36. 36.
    Lange JR, Palis BE, Chang DC, Soong SJ, Balch CM (2007) Melanoma in children and teenagers analysis of patients from the National Cancer data base. J Clin Oncol 25:1363–1368CrossRefGoogle Scholar
  37. 37.
    Joosse A, de Vries E, Eckel R et al (2011) Munich melanoma group. Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Investig Dermatol 131:719–726CrossRefGoogle Scholar
  38. 38.
    Joosse A, Collette S, Suciu S et al (2012) Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organization for research and treatment of cancer phase III trials. J Clin Oncol 30:2240–2247CrossRefGoogle Scholar
  39. 39.
    Karlsson PM, Fredrikson M (2007) Cutaneous malignant melanoma in children and adolescents in Sweden, 1993–2002: the increasing trend is broken. Int J Cancer 121:323–328CrossRefGoogle Scholar
  40. 40.
    Barnhill RL (2006) The spitzoid lesion: rethinking spitz tumors, atypical variant, “spitzoid melanoma” and risk assessment. Mod Pathol 19(2):S21–S33CrossRefGoogle Scholar
  41. 41.
    Berk DR, LaBuz E, Dadras SS et all (2010) Melanoma and melanocytic tumors of uncertain malignant potentialin children, adolescents and young adults: the Standford experience 1995–2008. Pediatr Dermatol 27:244–254CrossRefGoogle Scholar
  42. 42.
    Gill M, Cohen J, Renwick N et al (2004) Genetic similarities between spitz nevus and spitzoid melanoma in children. Cancer 101:2636–2640CrossRefGoogle Scholar
  43. 43.
    Lange JR, Balch CM (2005) Melanoma in children: heightened awareness of an uncommon but often curable malignancy. Pediatrics 115(3):802–803CrossRefGoogle Scholar
  44. 44.
    Averbook BJ, Lee SJ, Delman KA et al (2013) Pediatric melanoma analysis of international registry. Cancer 119(22):4012–4019CrossRefGoogle Scholar
  45. 45.
    Ferrari A, Bono A, Baldi M et al (2005) Does melanoma behave differently in younger children than in adults? A retrospettive study of 33 cases of childhood melanoma from a single institutions. Pediatrics 115:649–654CrossRefGoogle Scholar
  46. 46.
    Moore-Olufemi S, Herzog C, Warneke C et al (2011) Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patients. Ann Surg 253:1211–1215CrossRefGoogle Scholar
  47. 47.
    Kirkwood JM, Jukic DM, Averbook BJ et al (2009) Melanoma in pediatric, adolescent, and young adult patients. Semin Oncol 36:419–431CrossRefGoogle Scholar
  48. 48.
    Howman-Giles R, Shaw HM, Scolyer RA et al (2010) Sentinel lymph node biopsy in pediatric and teenager cutaneous melanoma patients. Ann Surg Oncol 17:138–143CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Giovanni Bagnoni
    • 1
  • Cristian Fidanzi
    • 1
  • Angelo Massimiliano D’Erme
    • 1
  • Paolo Viacava
    • 2
  • Matteo Leoni
    • 3
  • Silvia Strambi
    • 3
  • Chiara Calani
    • 3
  • Alessia Bertocchini
    • 3
  • Riccardo Morganti
    • 4
  • Claudio Spinelli
    • 3
  1. 1.Melanoma and Skin Cancer Unit AVNO (Area Vasta Nord Ovest) and Unit of DermatologyLivorno HospitalLivornoItaly
  2. 2.Unit of PathologyLivorno HospitalLivornoItaly
  3. 3.Pediatric, Adolescent and Young Adults Surgery Division, Department of Surgical, Medical, Pathological, Molecular and Critical AreaUniversity of PisaPisaItaly
  4. 4.Statistical Support to Clinical Trials DepartmentUniversity of PisaPisaItaly

Personalised recommendations